Prof. Charles Ng

Professor Charles Ng is a medical oncologist and surgeon at National University Hospital (NUH) in Singapore, specialising in gastrointestinal oncology and surgical oncology. With 25 years of clinical and academic experience, MBBS, MRCP, and FAMS qualifications, he occupies a leadership position in Singapore's premier university hospital and academic medical centre. National University Hospital is the flagship hospital of National University Health System (NUHS) and a global centre for cancer research and treatment, consistently attracting international patients for its multi-disciplinary oncology programmes. Professor Ng's professorial rank reflects sustained contribution to cancer medicine through clinical practice, research, and medical education.

Professor Ng completed his MBBS and achieved MRCP (Membership of the Royal College of Physicians, UK) — a highly regarded international physician qualification. He was subsequently awarded fellowship of the Academy of Medicine Singapore (FAMS), reflecting peer-recognised excellence in oncology within the Singapore medical community. His training in medical oncology encompassed systemic therapy including chemotherapy, targeted therapy, and immunotherapy for gastrointestinal cancers. His surgical oncology training provided expertise in oncological resection, combining medical and surgical approaches in a comprehensive cancer practice. He participates in ASCO, ESMO, and ACOS scientific programmes and has contributed to international cancer clinical trials.

Professor Ng's oncology practice focuses on gastrointestinal and related cancers, employing a multi-disciplinary team approach that integrates medical oncology, surgery, and clinical research. His gastrointestinal oncology expertise covers colorectal cancer, gastric cancer, oesophageal cancer, hepatocellular carcinoma, cholangiocarcinoma, and pancreatic cancer, applying systemic therapy including cytotoxic chemotherapy, targeted agents (anti-EGFR, anti-VEGF), and immune checkpoint inhibitors (PD-1/PD-L1 inhibitors). He contributes to tumour board decision-making and manages patients through the continuum from adjuvant therapy following resection to palliative systemic treatment. He has experience with participation in landmark clinical trials in GI oncology.

National University Hospital is Singapore's foremost academic medical centre and a globally recognised cancer treatment destination. Singapore's healthcare system — consistently ranked in the world's top tier — and NUH's comprehensive multi-disciplinary cancer programme attract international patients from Southeast Asia, South Asia, the Middle East, and beyond. The hospital offers dedicated international patient services including visa support, interpreters, accommodation coordination, and case management. Professor Ng consults in English and Mandarin. Singapore Changi Airport provides world-class connectivity, and NUH's research affiliations mean patients have access to cutting-edge clinical trial options alongside standard-of-care cancer treatment.

Professor Ng has been recognised by the National University of Singapore, the Academy of Medicine Singapore, and international oncology organisations for his contributions to gastrointestinal cancer treatment and research. His FAMS designation reflects peer evaluation within the Singapore medical establishment. He has been invited as faculty at ASCO, ESMO, and Asia-Pacific oncology conferences, and has contributed to peer-reviewed publications on GI cancer outcomes and clinical trial design. His professorial appointment at NUH reflects sustained excellence in cancer medicine education and research.